Faculty Disclosures

In accordance with the ACCME Standards for Commercial Support, course directors, planning committees, faculty and all others in control of the educational content of the CME activity must disclose all relevant financial relationships with any commercial interest that they may have had within the past 12 months. If an individual refuses to disclose relevant financial relationships, they will be disqualified from being a part of the planning and implementation of this CME activity. Owners and/or employees of a commercial interest with business lines or products relating to the content of the CME activity will not be permitted to participate in the planning or execution of any accredited activity.

Nature of Relevant Financial Relationship Last Name Role in Activity Commercial Interest What Was Received For What Role  Array, Regeneron  Acerta Pharma, Amgen, AstraZeneca, Bristol Myers Squibb, Dynavax, Genentech,  Honorarium  Advisory Board Idera, Inc., Incyte, ISA  Research Funding  Study Investigator Algazi Speaker Pharmaceuticals, LOXO Oncology,  Stock  Clinical Advisor Merck & Co., Novartis, Sensei  Honorarium, Stock  Clinical Advisor Biotherapeutics, Tessa Therapeutics  Valitor  Oncosec Medical

Ali Speaker  None  N/A  N/A

Daniels Speaker  None  N/A  N/A

Goodman Speaker  EUSA Pharma, Seattle Genetics  Honorarium  Consultant

 Acrotech Biopharma, Ipsen, Merck  Corcept Therapeutics, Regenacy Pharmaceuticals  Consultant  Honorarium  Abbvie, Advaxis, Amgen, Arcus  Advisory  Honorarium Hecht Speaker Biosciences, ARMO BioSciences, Board/Consultant  Grants Astellas, Eli Lilly, Forty Seven,  Research  Honorarium/Travel Gritstone Oncology, Halozyme,  Consultant Immunomedics, Merck & Co., Tesaro/GSK  Advaxis, Amgen, Eli Lilly

 Amgen, EMD Serono Inc.,  Grants  Research Support Kosty Speaker Genentech, Merck & Co.  Consulting Fees  Consultant  Biocept Inc.

 ADC Therapeutics, Amgen, Bristol Myers Squibb, Genentech, Mahindra Speaker  Honorarium  Advisory Board Gilead, Janssen, Oncopeptides, Sanofi, Takeda

Scripps MD Anderson’s 2021 Oncology Update July 10, 2021 and August 7, 2021 ● Live Streaming Virtual Event

 Data Safety  Puma  Honorarium Monitoring  Novartis  Honorarium Mortimer Speaker  Consultant  GSK, Mesoblast  Honorarium  ODAC Prep  AstraZeneca  Honorarium  Clinical Trail

 Astellas Pharma, AstraZeneca, Bayer, Bristol Myers Squibb, Exelixis, Genentech/Roche, Jannsen, Merck Sharp and  Advisory Dohme, Myovant, Novartis,  Honorarium Board/Education Pfizer, Seattle Genetics  Honorarium  Data Safety Quinn Speaker  US Biotest, Eisai  Grants Monitoring  Genentech/Roche, Merck & Co.,  Honorarium/Travel  Research Funding Pfizer  Advisory Board  Astellas Pharma, Bayer, Bristol Myers Squibb Japan, Exelixis, Merck & Co., Roche

Sarvaria Speaker  None  N/A  N/A

 AbbVie, Amgen, Bristol Myers Squibb, Dova Pharmaceuticals, GlaxoSmithKline, Incyte, Course Director,  Honorarium  Speakers Bureau Saven Karyopharm, Pharmacyclics, Moderator  Honorarium  Advisory Board Seattle Genetics  AstraZeneca, Innate Pharmaceutical  Scientific Advisory Board  Celularity  Equity  Scientific Advisory Sigal Speaker  Cend Therapeutics  Equity Board/Investor  Ipsen  Honorarium  Advisory Board/Speaker  AstraZeneca, Bristol Myers Srinivas Speaker Squibb, Bayer, Eisai, Exelixis,  Honorarium  Advisory Board Merck & Co., Seattle Genetics CME approval, all final CME Committee decision‐making on  None  N/A  N/A courses Plan, manage, Scripps Conference implement, and  None  N/A  N/A Services & CME reconcile activity

Glossary of Terms

Commercial Interest The ACCME defines a “commercial interest” as any entity producing, marketing, re‐selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.

Financial Relationships Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Scripps MD Anderson’s 2021 Oncology Update July 10, 2021 and August 7, 2021 ● Live Streaming Virtual Event

Conflict of Interest The ACCME considers financial relationships to create actual conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The ACCME considers “content of CME about the products or services of that commercial interest” to include content about specific agents/devices, but not necessarily about the class of agents/devices, and not necessarily content about the whole disease class in which those agents/devices are used. With respect to financial relationships with commercial interests, when a person divests themselves of a relationship it is immediately not relevant to conflicts of interest but it must be disclosed to the learners for 12 months.

Scripps MD Anderson’s 2021 Oncology Update July 10, 2021 and August 7, 2021 ● Live Streaming Virtual Event